NRX Pharmaceuticals Inc.(NRXP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NRXP NRX Pharmaceuticals Inc.

Market Closed 08-07 16:00:00 EDT

3.58

+0.49

+15.86%

盘后3.58

+0.00+0.11%

19:59 EDT

High4.15	Low3.37	Vol5.68M
Open3.50	D1 Closing3.09	Amplitude25.21%
Mkt Cap150.16M	Tradable Cap129.59M	Total Shares41.94M
T/O21.00M	T/O Rate15.68%	Tradable Shares36.20M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NRXP","market":"US","secType":"STK","nameCN":"NRX Pharmaceuticals Inc.","latestPrice":3.58,"timestamp":1786132800000,"preClose":3.09,"halted":0,"volume":5676501,"hourTrading":{"tag":"盘后","latestPrice":3.5838,"preClose":3.58,"latestTime":"19:59 EDT","volume":54587,"amount":195279.0659,"timestamp":1786147158766,"change":0.0038,"changeRate":0.001061,"amplitude":0.047374},"delay":0,"changeRate":0.15857605177993536,"floatShares":36197200,"shares":41943300,"eps":-0.966884,"marketStatus":"Market Closed","change":0.49,"latestTime":"08-07 16:00:00 EDT","open":3.5,"high":4.1497,"low":3.3706,"amount":20996885.0463633,"amplitude":0.252136,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.966884,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1786348800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":3.09,"preHourTrading":{"tag":"盘前","latestPrice":3.45,"preClose":3.09,"latestTime":"09:29 EDT","volume":389692,"amount":1361839.7197672,"timestamp":1786109399999,"change":0.36,"changeRate":0.116505,"amplitude":0.203883},"postHourTrading":{"tag":"盘后","latestPrice":3.5838,"preClose":3.58,"latestTime":"19:59 EDT","volume":54587,"amount":195279.0659,"timestamp":1786147158766,"change":0.0038,"changeRate":0.001061,"amplitude":0.047374},"volumeRatio":6.663413901171944,"impliedVol":2.2437,"impliedVolPercentile":0.8486},"requestUrl":"/m/hq/s/NRXP","defaultTab":"news","newsList":[{"id":"2657626537","title":"NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2657626537","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657626537?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:01","pubTimestamp":1786132860,"startTime":"0","endTime":"0","summary":"Conference Call 8:30 a.m. ET, Monday, August 10, 2026MIAMI, Aug.  07, 2026  (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (\"NRx Pharmaceuticals\", the \"Company\"), a clinical-stage biopha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/07/3341373/0/en/nrx-pharmaceuticals-inc-nasdaq-nrxp-to-host-conference-call-august-10-to-discuss-fda-first-cycle-anda-review-and-commercial-plans.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDX","NQmain","GPIQ","NRXP","HST","NVIW.SI","BK4007","TQQY","PSIL","IYW","QYLG","BK4585","BK4218","FTEC","LABU","PSQ","QQQY",".IXIC","QQQA","QQQJ","SQQQ","TECS","JEPQ","QQQM","BK4588","ONEQ","MNQmain","QQQ","QID","QQQE","TQQQ","QLD","QDTE","BK4181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657640437","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: NRX Pharmaceuticals (NRXP), Novo Nordisk (NVO) and Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657640437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657640437?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:30","pubTimestamp":1786120219,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on NRX Pharmaceuticals (NRXP), Novo Nordisk (NVO) and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-nrx-pharmaceuticals-nrxp-novo-nordisk-nvo-and-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-nrx-pharmaceuticals-nrxp-novo-nordisk-nvo-and-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0321505439.SGD","BK4007","BK4588","LU0306806265.USD","LU0868494617.USD","LU2596442595.SGD","SG9999011175.SGD","NVOX","LU0058720904.USD","THNR","BK4532","IE00B3T34201.USD","IE00BBT3K403.USD","BK4550","IE000M9KFDE8.USD","SG9999002232.USD","LU0321505868.SGD","LU0225284248.USD","LU1066051498.USD","NRXP","IE00BKVL7J92.USD","LU0225771236.USD","LU0306807586.USD","LU0234572021.USD","LU1894683348.USD","OZEM","NVO","BK4585","SG9999001176.USD","LU1894683264.USD","SG9999002224.SGD","LU0456855351.SGD","LU0985481810.HKD","LU1093756325.SGD","SGXZ57979304.SGD","LU1883839398.USD","SG9999001176.SGD","LU1093756168.USD","IE00BLSP4239.USD","LU0170899867.USD","BK4533","IE00BLSP4452.SGD","LU1023059063.AUD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","IE0002270589.USD","LU1057294990.SGD","LU1066053197.SGD","BK4592","BK4581","BK4599","NVOH","PPH","SG9999013999.USD","BK4534","IE00B19Z3B42.SGD","PFE","BK4568","LU0122379950.USD","LU0154236417.USD","LU0289739699.SGD","PSIL","SG9999003800.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657980640","title":"NRx Pharmaceuticals Shares Rise After FDA Finishes Ketamine Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2657980640","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657980640?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:24","pubTimestamp":1786119840,"startTime":"0","endTime":"0","summary":"NRx Pharmaceuticals shares rose after the Food and Drug Administration completed its abbreviated new drug application review of the company's ketamine product.The stock climbed 21% to $3.73 on Friday. Shares are up 42% this year.The first-cycle review evaluated NRx's preservative-free ketamine and found no major deficiencies related to the product, ingredients or labeling, the drug company said Friday.The FDA did flag a remaining question related to the container closure of the medication vial. The issue is packaging-related and doesn't relate to the ketamine drug product itself, NRx said.The company is providing an attestation to the FDA related to the packaging issue.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","BK4585","PSIL","BK4007","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657610077","title":"FDA completes review of NRx Pharmaceuticals preservative-free ketamine ANDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2657610077","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657610077?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:21","pubTimestamp":1786101688,"startTime":"0","endTime":"0","summary":"NRx Pharmaceuticals (NRXP) announced that the FDA has completed first-cycle review of the company’s ANDA for its preservative-free ketamine, with n...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-completes-review-of-nrx-pharmaceuticals-preservative-free-ketamine-anda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-completes-review-of-nrx-pharmaceuticals-preservative-free-ketamine-anda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","LABU","BK4007","NRXP","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657061084","title":"FDA Flags Packaging Certification as Sole Major Deficiency for NRx Preservative-Free Ketamine ANDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2657061084","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657061084?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:01","pubTimestamp":1786100507,"startTime":"0","endTime":"0","summary":"FDA flags packaging certification as sole major deficiency for NRx preservative-free ketamine ANDA approvalFDA completed first-cycle review of NRX Pharmaceuticals’ preservative-free ketamine ANDA with","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL6YBV6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","LU0728928796.USD","LU0640478920.SGD","LU0282719219.EUR","IE00B3QW5Z07.USD","BK4007","IE00BN0W2V16.EUR","LU0757432629.USD","LU1815337495.USD","LU1815337578.USD","IE00BN0W2T93.GBP","BK4112","FAN.UK","SG9999014039.USD","SG9999014021.USD","PSIL","BK4585","BK4588","IE00BN0W2W23.USD","LU0314104364.USD","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","SG9999014005.SGD","IE00B64PRP62.GBP","BK5026","SG9999014013.SGD","LU2210150020.SGD","LU2095319765.USD","IE00BKPKM429.USD","NRXP","LU0757432546.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657617099","title":"NRX Pharmaceuticals - FDA Finds no Major Deficiencies in Ketamine Anda First-Cycle Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2657617099","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657617099?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:00","pubTimestamp":1786100400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nTUA1BNQYL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657617087","title":"NRX Pharmaceuticals - no New Clinical or Safety Data Required for Ketamine Anda Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2657617087","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657617087?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:00","pubTimestamp":1786100400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nTUA1BNQYL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRXP","PSIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657170556","title":"NRX Pharmaceuticals - FDA to Review Certification in Shortest Possible Cycle After Aug 6, 2026 Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2657170556","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657170556?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:00","pubTimestamp":1786100400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nTUA1BNQYL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRXP","PSIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657161707","title":"FDA Completes First-Cycle Review of Preservative-Free Ketamine Anda with no Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2657161707","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657161707?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:00","pubTimestamp":1786100400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nTUA1BNQYL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653754039","title":"NRX Pharmaceuticals - on July 21, Nrxd Selected by Darpa for Negotiation of Potential Sparc-tms Clinical Trial Award - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2653754039","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653754039?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:08","pubTimestamp":1784718511,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nFWN43O0MI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651449806","title":"Market Sentiment Around Loss-Making NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651449806","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651449806?lang=en_us&edition=fundamental","pubTime":"2026-07-16 18:58","pubTimestamp":1784199515,"startTime":"0","endTime":"0","summary":"With the business potentially at an important milestone, we thought we'd take a closer look at NRx Pharmaceuticals...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nrxp/nrx-pharmaceuticals/news/market-sentiment-around-loss-making-nrx-pharmaceuticals-inc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nrxp/nrx-pharmaceuticals/news/market-sentiment-around-loss-making-nrx-pharmaceuticals-inc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NRXP","IYW",".IXIC","ONEQ","QQQA","QQQ","QDTE","QLD","QID","TQQY","QQQM","TQQQ","QQQY","QYLG","QQQE","SQQQ","JEPQ","PSIL","FTEC","QQQJ","NVIW.SI","NQmain","BK4007","NDX","TECS","GPIQ","MNQmain","PSQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646385379","title":"Nrx Pharmaceuticals Pushes Kadima Dispute into Arbitration Amid Acquisition Lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=2646385379","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646385379?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:01","pubTimestamp":1782417679,"startTime":"0","endTime":"0","summary":"NRx Pharmaceuticals pushes Kadima dispute into arbitration amid acquisition lawsuitNRX Pharmaceuticals disclosed it has compelled arbitration with Kadima Neuropsychiatry Institute over a failed HOPE T","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL15N3MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014039.USD","BK4007","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","LU2210149790.SGD","SG9999014021.USD","SG9999014013.SGD","LU2210150020.SGD","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU0314104364.USD","SG9999014005.SGD","BK4112","IE00BN0W2V16.EUR","NRXP","BK4588","NDAQ","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646385378","title":"NRX Pharmaceuticals - Initiates Arbitration with Kadima over Failed Closing Conditions","url":"https://stock-news.laohu8.com/highlight/detail?id=2646385378","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646385378?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:01","pubTimestamp":1782417668,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nFWN42X0T4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646385347","title":"NRX Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2646385347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646385347?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:01","pubTimestamp":1782417668,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nFWN42X0T4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646238530","title":"NRX Pharmaceuticals: Co Does not Believe That Acquisition/non-acquisition of Any Individual Clinic Would be Material to Hope's Overall Business Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2646238530","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646238530?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:01","pubTimestamp":1782417668,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nFWN42X0T4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646436808","title":"H.C. Wainwright Keeps Their Buy Rating on NRX Pharmaceuticals (NRXP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2646436808","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646436808?lang=en_us&edition=fundamental","pubTime":"2026-06-25 20:36","pubTimestamp":1782390990,"startTime":"0","endTime":"0","summary":"In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on NRX Pharmaceuticals, with a price target of $45.00. Tr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-nrx-pharmaceuticals-nrxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-nrx-pharmaceuticals-nrxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646728328","title":"Nrx Subsidiary HOPE Therapeutics Begins Patient Treatments Using Zeta Surgical TMS Navigation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2646728328","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646728328?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:02","pubTimestamp":1782385355,"startTime":"0","endTime":"0","summary":"NRx subsidiary HOPE Therapeutics begins patient treatments using Zeta Surgical TMS navigation systemNRX Pharmaceuticals subsidiary HOPE Therapeutics began treating patients using Zeta Surgical’s FDA-c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL919kzx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BN0W2W23.USD","BK4007","SG9999014039.USD","LU2210149790.SGD","SG9999014013.SGD","NDAQ","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","LU0314104364.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","BK4112","IE00BKPKM429.USD","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014021.USD","NRXP","BK4588","SG9999014005.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646874700","title":"NRX Pharmaceuticals (nasdaq: Nrxp) Subsidiary Hope Therapeutics Treats First Patients Using Zeta Surgical's Fda-cleared Zeta Tms Navigation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2646874700","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646874700?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:00","pubTimestamp":1782385229,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nFWN42W14V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646817039","title":"Kadima Neuropsychiatry Institute alleges NRx breached contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2646817039","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646817039?lang=en_us&edition=fundamental","pubTime":"2026-06-25 01:25","pubTimestamp":1782321915,"startTime":"0","endTime":"0","summary":"Kadima Neuropsychiatry Institute and its founder, Dr. David Feifel, said the have filed a complaint against NRx Pharmaceuticals (NRXP) in San Diego...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kadima-neuropsychiatry-institute-alleges-nrx-breached-contract-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kadima-neuropsychiatry-institute-alleges-nrx-breached-contract-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646381760","title":"Kadima Neuropsychiatry Institute Files Suit Against NRX Pharmaceuticals (nasdaq: Nrxp), Alleging Breach of Contract and Misrepresentation in Connection with Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2646381760","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646381760?lang=en_us&edition=fundamental","pubTime":"2026-06-25 01:19","pubTimestamp":1782321545,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nFWN42W0SN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.salbergco.com","stockEarnings":[{"period":"1week","weight":0.1365},{"period":"1month","weight":-0.0867},{"period":"3month","weight":0.1623},{"period":"6month","weight":0.8743},{"period":"1year","weight":0.4553},{"period":"ytd","weight":0.321}],"compareEarnings":[{"period":"1week","weight":0.0351},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1197},{"period":"1year","weight":0.223},{"period":"ytd","weight":0.1339}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned food and drug administration-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior. The company has a partnership with Alvogen Inc. and Lotus Pharmaceutical Company; development and manufacturing agreement with Nephron Pharmaceuticals, Inc. and Alcami; license agreement with Apkarian Technologies; development and license agreement with Glytech; license agreement with Sarah Herzog Memorial Hospital. The company was founded in 2015 and is based in Wilmington, Delaware.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.074525},{"month":2,"riseRate":0.2,"avgChangeRate":-0.102766},{"month":3,"riseRate":0.4,"avgChangeRate":-0.034339},{"month":4,"riseRate":0.4,"avgChangeRate":-0.100305},{"month":5,"riseRate":0.8,"avgChangeRate":0.153649},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.15132},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.005215},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.095674},{"month":9,"riseRate":0.4,"avgChangeRate":-0.012776},{"month":10,"riseRate":0.6,"avgChangeRate":0.037482},{"month":11,"riseRate":0.4,"avgChangeRate":0.048439},{"month":12,"riseRate":0.6,"avgChangeRate":0.121824}],"exchange":"NASDAQ","name":"NRX Pharmaceuticals Inc.","nameEN":"NRX Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NRX Pharmaceuticals Inc.(NRXP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest NRX Pharmaceuticals Inc.(NRXP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"NRX Pharmaceuticals Inc.,NRXP,NRX Pharmaceuticals Inc.股票,NRX Pharmaceuticals Inc.股票老虎,NRX Pharmaceuticals Inc.股票老虎国际,NRX Pharmaceuticals Inc.行情,NRX Pharmaceuticals Inc.股票行情,NRX Pharmaceuticals Inc.股价,NRX Pharmaceuticals Inc.股市,NRX Pharmaceuticals Inc.股票价格,NRX Pharmaceuticals Inc.股票交易,NRX Pharmaceuticals Inc.股票购买,NRX Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NRX Pharmaceuticals Inc.(NRXP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest NRX Pharmaceuticals Inc.(NRXP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction